Primaquine (Compound)

Synonyms:PRIMAQUINE, 90-34-6, Primachin, 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline, Neo-Quipenyl, Primaquin, Primachinum, Primaquinum, Primaquina, Kanaprim, (+/-)-Primaquine, 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine, 6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline, N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine, SN 13,272, Maliride, S. N. 13272, NSC 27296, Primaquine (INN), WR 2975, CHEBI:8405, N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine, 8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline, NSC-27296, MVR3634GX1, (+)-Primaquine, (-)-Primaquine, NSC27296, 1,4-Pentanediamine, N(4)-(6-methoxy-8-quinolinyl)-, 8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline, WR-2975, N-[(S)-4-Amino-1-methylbutyl]-6-methoxy-8-quinolinamine, Primachina [DCIT], Primachina, SN-13272, dl-Primaquine, PRIMAQUINE [INN], Primaquine [INN:BAN], BRN 0019337, Maliride; NSC 27296; Neo-Quipenyl; Primachin, N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine, Primaquinum [INN-Latin], Primaquina [INN-Spanish], 6-Methoxy-8-[(4-amino-1-methylbutyl)amino]quinoline, N~4~-[6-(methyloxy)quinolin-8-yl]pentane-1,4-diamine, Quinoline, 8-((4-amino-1-methylbutyl)amino)-6-methoxy-, CHEMBL506, MLS001334045, Kanaprim (TN), CCRIS 4109, HSDB 6516, 4-22-00-05817 (Beilstein Handbook Reference), NCGC00178754-06, N~4~-(6-methoxyquinolin-8-yl)pentane-1,4-diamine, SMR000875314, EINECS 201-987-2, 6-Methoxy-8-((4-amino-1-methylbutyl)amino)quinoline, Quinoline, 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-, UNII-MVR3634GX1, Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy, (RS)-primaquine, TG1-296, TG1-297, Spectrum_000830, PRIMAQUINE [MI], Prestwick0_000476, Prestwick1_000476, Prestwick2_000476, Prestwick3_000476, Spectrum2_000887, Spectrum3_000552, Spectrum4_000484, Spectrum5_001363, PRIMAQUINE [VANDF], Epitope ID:131792, PRIMAQUINE [WHO-DD], Oprea1_546209, SCHEMBL22207, BSPBio_000612, BSPBio_002223, KBioGR_000967, KBioSS_001310, DivK1c_000806, N(4)-(6-methoxyquinolin-8-yl)pentane-1,4-diamine, SPBio_000674, SPBio_002551, (+)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine, (-)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine, BPBio1_000674, cid_359247, GTPL9952, Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy-, DTXSID8023509, BDBM71542, KBio1_000806, KBio2_001310, KBio2_003878, KBio2_006446, KBio3_001723, NINDS_000806, HMS2090J17, BCP29271, BBL011330, HY-12651A, MFCD00598906, STL146416, 1, N4-(6-methoxy-8-quinolinyl)-, AKOS005721199, DB01087, WLN: T66 BNJ HO1 JMY1&3Z, IDI1_000806, SMP1_000263, NCGC00178754-01, NCGC00178754-02, NCGC00178754-03, AC-23007, AS-30679, NCI60_001035, NCI60_005887, SBI-0051491.P003, AB00053529, CS-0013754, FT-0687514, C07627, D08420, EN300-144245, AB00053529-11, AB00053529_12, AB00053529_14, N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine, A843518, N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine, Q419834, BRD-A55913614-316-06-2, SR-05000001864-11, N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine;Primaquine, N4-(6-Methoxyquinolin-8-yl)pentane-1,4-diamine (2 H3PO4), N4-(6-methoxy-8-quinolinyl)pentane-1,4-diamine;phosphoric acid, N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine;phosphoric acid, (4-amino-1-methyl-butyl)-(6-methoxy-8-quinolyl)amine;phosphoric acid
Pubchem:PUBCHEM:4908
Id:41e36a1f-364b-511c-8e86-bee54b1a4a9d
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Primaquine's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Primaquine.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Primaquine.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.